Posted on 2/11/21
Steve Boutin to Serve as CEO of Sensible Medical
Sensible Medical, a Hanover, MA distributor of medical grade air purification systems for hospitals, clinics and offices
Posted on 2/11/21
Foundation Source Names Sunil Garga CEO
Foundation Source, the nation's largest provider of comprehensive support services to private foundations, today announces
Posted on 2/10/21
Synlogic Appoints Lisa Kelly-Croswell to Board
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Lisa Kelly-Croswell to its . . .
Posted on 2/10/21
Beta Bionics Appoints Martha Goldberg Aronson as Chair of Its Board of Directors
Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet
Posted on 2/9/21
Osram Sylvania Appoints Mark Savoy as CEO
Osram Sylvania, the leader in automotive lighting solutions for the automotive aftermarket and original equipment manufacturers (OEMs), announced the appointment of Mark Savoy
Posted on 2/11/21
Citybiz Interview with Michael Mikhail, CEO & Founder of Stratton Equities
Michael Mikhail is the Founder and CEO of Stratton Equities, the Nation’s Leading Hard Money and NON-QM
Posted on 2/9/21
Hamilton Thorne Appoints Feng Han to Board of Directors
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies
Posted on 2/9/21
Ironwood Pharmaceuticals Appoints Thomas McCourt Interim CEO
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Mark Mallon
Posted on 2/8/21
Editas Medicine Appoints James C. Mullen as CEO
Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that James (Jim) C. Mullen will succeed Cynthia (Cindy) Collins as Chief Executive Officer, . . .
Posted on 2/8/21
Palleon Pharmaceuticals Appoints Nikola Trbovic to Its Board of Directors
Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, today announced the appointment of Nikola Trbovic, Ph.D.,
Posted on 2/5/21
Ziopharm Oncology Elects Robert Postma to its Board of Directors
BOSTON, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors, effective immediately. Mr. Postma . . .
Posted on 2/5/21
AVANGRID Appoints Catherine Stempien CEO of Avangrid Networks
AVANGRID, Inc. (NYSE: AGR), a leading sustainable energy company, announced today the appointment of Catherine S. Stempien
Posted on 2/4/21
W. R. Berkley Corp. Names David Brosnan CEO of W. R. Berkley Syndicate Management Limited
W. R. Berkley Corporation (NYSE: WRB) today announced the appointment of David Brosnan as chief executive
Posted on 2/4/21
PepGen Appoints James McArthur, Ph.D., as CEO
PepGen, a biotechnology company focused on transforming the care of patients with neuromuscular diseases through the enhanced delivery of therapeutic oligonucleotides, today announced the appointment of . . .
Posted on 2/4/21
Shawn Tomasello Joins TCR² Therapeutics Board of Directors
TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer
Posted on 2/4/21
Catamaran Bio Appoints Dr. Alvin Shih as CEO
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need, today announced the appointment of Alvin Shih, . . .
Posted on 2/3/21
Invaio Sciences Formation of World-Class Scientific Advisory Board
Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet's interdependent natural systems to solve pressing agriculture
Posted on 2/3/21
Open Implants Appoints Gregg M. Gellman as Chief Executive Officer
The Board of Directors of Open Implants LLC is pleased to announce the appointment of Gregg M. Gellman as the organization's new Chief Executive Officer. With . . .
Posted on 2/3/21
Dynatrace Appoints Jill Ward as Chair of its Board of Directors
WALTHAM, Mass.--(BUSINESS WIRE)--Software intelligence company, Dynatrace (NYSE: DT), today announced it has appointed non-executive, independent board member Jill Ward as chair. Ms. Ward, an experienced board . . .
Posted on 2/3/21
smartShift Appoints Derek Oats as CEO
smartShift, known for its intelligent automation platform for SAP and Cloud digital transformations
Posted on 2/2/21
Michael Remacle and Alex Zolotar Join Fonative to its Board of Advisors
Fonative, the Compliant Communications CPaaS company, has strengthened its leadership and product management team with the addition of Alex Zolotar
Posted on 2/2/21
Lauren Webb Joins The Quell Foundation Board of Directors
The Quell Foundation is honored to announce the following leadership changes effective February 1, 2021. Formerly a member of The Foundation's Executive Advisory Board, Lauren Webb, . . .
Posted on 2/2/21
Stilla Appoints Philippe Mourere as CEO
Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and Founder Dr. Rémi Dangla has . . .
Posted on 2/2/21
iSun Appoints Claudia Meer to Board
iSun, Inc. (NASDAQ: ISUN) a leading solar energy, smart city and clean mobility infrastructure innovator with 50 years of construction expertise for solar, electrical and data . . .
Posted on 2/2/21
Revitope Oncology Appoints Louis Lange to its Board of Directors
Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies, today announced the appointment of biotechnology pioneer Louis Lange, M.D., Ph.D., to . . .
Boston
